Trophos
Roche - Roche acquires Trophos to expand portfolio in neuromuscular disease with high medical need.
Launch date
Market cap
-
Enterprise valuation
€496m (Public information from Jan 2015)
Marseille Provence-Alpes-Côte d'Azur (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€8.5m | Series C | ||
$546m Valuation: $546m | Acquisition | ||
| Total Funding | €8.5m | ||